Evidence map›Paper›PMID 16855615›Full record

ArticleGene therapy2006

Magnetic resonance imaging of viral particle biodistribution in vivo.

J K Räty, T Liimatainen, T Wirth, K J Airenne, T O Ihalainen, T Huhtala, E Hamerlynck, M Vihinen-Ranta, A Närvänen, S Ylä-Herttuala and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Gene therapy, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Toxicological Aspects of Iron Oxide Nanoparticles.Advances in experimental medicine and biology · 2022
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Hybrid nanoparticles for detection and treatment of cancer.Advanced materials (Deerfield Beach, Fla.) · 2012
    Review
  9. Article
  10. Review
  11. Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer.International journal of molecular epidemiology and genetics · 2011
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Non-invasive genetic imaging for molecular and cell therapies of cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2007
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

J K RätyDepartment of Biotechnology and Molecular Medicine, University of Kuopio, Kuopio, Finland. jani.raty@uku.fi
T Liimatainen
T Wirth
K J Airenne
T O Ihalainen
T Huhtala
E Hamerlynck
M Vihinen-Ranta
A Närvänen
S Ylä-Herttuala
J M Hakumäki
University of Eastern Finland · FIInstitute for Molecular Medicine Finland · FIUniversity of Jyväskylä · FIArk Therapeutic (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe here a technique for the visualization of viral vector delivery by magnetic resonance imaging (MRI) in vivo. By conjugating avidin-coated baculoviral vectors (Baavi) with biotinylated ultra-small superparamagnetic iron oxide particles (USPIO), we are able to produce vector-related MRI contrast in the choroid plexus cells of rat brain in vivo over a period of 14 days. Ten microlitres of 2.5 x 10(10) PFU/ml nuclear-targeted LacZ-encoding Baavi with bUSPIO coating was injected into rat brain ventricles and visualized by MRI at 4.7 T. As baculoviruses exhibit restricted cell-type specificity in the rat brain, altered MRI contrast was detected in the choroid plexus of the injected ventricles. No specific signal loss was detected when wild-type baculoviruses or intact biotinylated USPIO particles were injected into the lateral ventricles. Cryosectioned brains were stained for nuclear-targeted beta-galactosidase gene expression, which was found to colocalize with MRI contrast. This study provides the first proof of principle for robust and non-invasive viral vector MRI by using avidin-displaying viruses in vivo. Considering the widespread use of MRI in current medical imaging, the approach is likely to provide numerous future applications in imaging of therapeutic gene transfer.

Indexed as

Magnetic Resonance ImagingAnimalsBaculoviridaebeta-GalactosidaseBiomarkersBrainFerric CompoundsGenetic TherapyGenetic VectorsNanoparticlesRatsTissue DistributionTransduction, Geneticbeta-GalactosidaseBiomarkersFerric Compoundsferric oxide

Identifiers

PMID16855615
OpenAlexW2051502464

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.